Accellta provides custom-made solutions for mass production of high quality human embryonic and induced pluripotent stem cells, progenitors and differentiated cells for drug discovery, regenerative medicine and research. Culturing is conducted in 3D suspension systems under feeder-free, adherent-free and xeno-free conditions. The tailored solutions dramatically reduce production time and costs.
.png)
Meet Us
ISSCR 2016 Annual Meeting, June 22-25, San Francisco, US
ISSCR International Symposia, 22-24 March 2016, Kyoto, Japan
Bio Europe Spring, 4-6 April 2016, Stockholm, Sweden
Israstem Joint Annual Meeting, April 5-6 2016, Tel-Aviv, Israel
The Red Herring 100 Europe 2016, April 11 2016, Amsterdam, Netherlands
Bio International Convention, June 6-9 2016, San Francisco, US
-
Pluripotent stem cells cultured as single-cells in suspension, providing enhanced uniformity and purity, serving as a platform for genetic manipulation. -
Pluripotent stem cells cultured as aggregates in dynamic suspension devoid of feeder cell layer and/or microcarriers.
Accellta chosen as a 2016 Red Herring Top 100 Europe Winner
3D Suspension Culturing
Feeder-free, Adherent-free, Xeno-free conditions
Directed differentiation of pluripotent stem cells in suspension
Partnering and collaboration
Contact Us
+972.4.8291070
info@accellta.com| All rights reserved to Accellta Ltd. 2013 | PearlCom |  Web Design |